Literature DB >> 20594522

Percutaneous transluminal cerebral angioplasty and stenting in acute vertebrobasilar ischemic stroke. Report of two cases.

M Nistri1, S Mangiafico, M Cellerini, G Villa, P Mennonna, F Ammannati, G P Giordano.   

Abstract

SUMMARY: Reports of cerebral transluminal angioplasty and stenting in patients with vertebrobasilar ischemic stroke are scanty. Herein we report on the use of "monorail" coronary balloon angioplasty and stent balloon mounted catheters in two patients with acute vertebrobasilar ischemic stroke, focussing on the differences and possible advantages of the "monorail" technique in comparison with the "over-the-wire" technique. In both patients, the clinical picture was characterized by progressive brainstem symptoms followed by acute loss of consciousness related to an atherothrombotic occlusion and subocclusion of the dominant intracranial vertebral artery, respectively. In one patient, superselective thrombolytic therapy and balloon angioplasty resulted in a dissection flap at the vertebrobasilar junction. The latter was treated by successful deployment of a coronary stent. In the other patient, the subocclusive lesion was directly treated by angioplasty and stenting without thrombolytic therapy. The clinical outcome was poor for one patient ("locked in" syndrome) while the other had a complete clinical recovery. In acute atherothrombotic vertebrobasilar stroke transluminal cerebral angioplasty and stenting may be successfully performed allowing vessel recanalization.

Entities:  

Year:  2004        PMID: 20594522      PMCID: PMC3576607          DOI: 10.1177/159101990200800205

Source DB:  PubMed          Journal:  Interv Neuroradiol        ISSN: 1591-0199            Impact factor:   1.610


  14 in total

1.  Primary stenting for high-grade basilar artery stenosis.

Authors:  C C Phatouros; J E Lefler; R T Higashida; P M Meyers; A M Malek; C F Dowd; V V Halbach
Journal:  AJNR Am J Neuroradiol       Date:  2000-10       Impact factor: 3.825

Review 2.  Prevention and treatment of thromboembolic and ischemic complications associated with endovascular procedures: Part I--Pathophysiological and pharmacological features.

Authors:  A I Qureshi; A R Luft; M Sharma; L R Guterman; L N Hopkins
Journal:  Neurosurgery       Date:  2000-06       Impact factor: 4.654

Review 3.  The use of stents in the management of neurovascular disease: a review of historical and present status.

Authors:  M B Horowitz; P D Purdy
Journal:  Neurosurgery       Date:  2000-06       Impact factor: 4.654

4.  Abciximab as an adjunct to high-risk carotid or vertebrobasilar angioplasty: preliminary experience.

Authors:  A I Qureshi; M F Suri; J Khan; R D Fessler; L R Guterman; L N Hopkins
Journal:  Neurosurgery       Date:  2000-06       Impact factor: 4.654

Review 5.  Prevention and treatment of thromboembolic and ischemic complications associated with endovascular procedures: Part II--Clinical aspects and recommendations.

Authors:  A I Qureshi; A R Luft; M Sharma; L R Guterman; L N Hopkins
Journal:  Neurosurgery       Date:  2000-06       Impact factor: 4.654

6.  Elective stenting of symptomatic basilar artery stenosis.

Authors:  C R Gomez; V K Misra; M W Liu; V R Wadlington; J B Terry; R Tulyapronchote; M S Campbell
Journal:  Stroke       Date:  2000-01       Impact factor: 7.914

7.  Thrombolytic therapy of acute basilar artery occlusion. Variables affecting recanalization and outcome.

Authors:  T Brandt; R von Kummer; M Müller-Küppers; W Hacke
Journal:  Stroke       Date:  1996-05       Impact factor: 7.914

8.  Stent-assisted angioplasty of intracranial vertebrobasilar atherosclerosis: an initial experience.

Authors:  P A Rasmussen; J Perl; J D Barr; G Z Markarian; I Katzan; C Sila; D Krieger; A J Furlan; T J Masaryk
Journal:  J Neurosurg       Date:  2000-05       Impact factor: 5.115

9.  Follow-up study after intracranial percutaneous transluminal cerebral balloon angioplasty.

Authors:  T Mori; M Fukuoka; K Kazita; K Mori
Journal:  AJNR Am J Neuroradiol       Date:  1998-09       Impact factor: 3.825

10.  Prognosis of patients with symptomatic vertebral or basilar artery stenosis. The Warfarin-Aspirin Symptomatic Intracranial Disease (WASID) Study Group.

Authors: 
Journal:  Stroke       Date:  1998-07       Impact factor: 7.914

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.